CytoReason - Artificial Intelligence Machine Learning - Next Digital Health

CytoReason is a data-focused technology company headquartered in Tel Aviv, Israel. Founded in 2016, it uses its AI-powered platform to help therapeutic leaders, scientists, and research teams make more informed decisions. The company expanded its partnership with Pfizer in 2022 and later added three more pharmaceutical companies, extending its coverage to disease models related to the central nervous system (CNS).
read more..